SMARCB1在滑膜肉瘤发生中的作用揭示SS18-SSX诱导经典BAF复合物降解
本研究探讨SMARCB1在滑膜肉瘤发生中的角色。小鼠实验表明,Smarcb1基因缺失与SS18-SSX表达协同产生侵袭性肿瘤,其组织形态、转录组和全基因组BAF家族复合物分布与单独SS18-SSX不同,提示SMARCB1在滑膜肉瘤中起定义性作用。在人类细胞中,SS18-SSX表达导致经典BAF复合物整体降解,使PBAF和GBAF复合物相对丰度增加,从而改变BAF亚型平衡和基因组分布,驱动滑膜肉瘤发生。
要点
- SMARCB1在滑膜肉瘤中起定义性作用,与SS18-SSX协同促进肿瘤发生。
- SS18-SSX诱导经典BAF复合物降解,改变BAF亚型平衡和基因组分布。
- SMARCB1整合入PBAF和含SS18-SSX的经典BAF复合物中。
核心结论
- SS18-SSX通过诱导经典BAF复合物整体降解,改变BAF亚型水平和基因组分布,驱动滑膜肉瘤发生,SMARCB1在其中起定义性作用。
研究设计与样本
- 研究采用小鼠遗传学实验(Smarcb1基因缺失与SS18-SSX表达联合)及人类细胞实验,分析肿瘤组织形态、转录组和BAF复合物分布。
主要发现
- Smarcb1基因缺失与SS18-SSX表达在小鼠中协同产生侵袭性肿瘤,其组织形态、转录组和全基因组BAF家族复合物分布与单独SS18-SSX不同。
- 单独Smarcb1沉默在小鼠间充质中模拟上皮样肉瘤发生。
- 在小鼠和人类滑膜肉瘤细胞中,SMARCB1存在于PBAF和经典BAF复合物中,并与SS18-SSX共整合于后者。
- 在人类细胞中重组表达经典BAF组分可重建经典BAF亚复合物,无论包含SS18还是SS18-SSX,SMARCB1水平相等。
- 体内实验显示,SS18-SSX表达导致经典BAF复合物整体降解,随时间推移PBAF和GBAF复合物相对丰度增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reduced protein levels of SMARCB1 (also known as BAF47, INI1, SNF5) have long been observed in synovial sarcoma. Here, we show that combined Smarcb1 genetic loss with SS18-SSX expression in mice synergized to produce aggressive tumors with histomorphology, transcriptomes, and genome-wide BAF-family complex distributions distinct from SS18-SSX alone, indicating a defining role for SMARCB1 in synovial sarcoma. Smarcb1 silencing alone in mesenchyme modeled epithelioid sarcomagenesis. In mouse and human synovial sarcoma cells, SMARCB1 was identified within PBAF and canonical BAF (CBAF) complexes, coincorporated with SS18-SSX in the latter. Recombinant expression of CBAF components in human cells reconstituted CBAF subcomplexes that contained equal levels of SMARCB1 regardless of SS18 or SS18-SSX inclusion. In vivo, SS18-SSX expression led to whole-complex CBAF degradation, rendering increases in the relative prevalence of other BAF-family subtypes, PBAF and GBAF complexes, over time. Thus, SS18-SSX alters BAF subtypes levels/balance and genome distribution, driving synovial sarcomagenesis. SIGNIFICANCE: The protein level of BAF component SMARCB1 is reduced in synovial sarcoma but plays a defining role, incorporating into PBAF and SS18-SSX-containing canonical BAF complexes. Reduced levels of SMARCB1 derive from whole-complex degradation of canonical BAF driven by SS18-SSX, with relative increases in the abundance of other BAF-family subtypes.See related commentary by Maxwell and Hargreaves, p. 2375.This article is highlighted in the In This Issue feature, p. 2355.
引用
- Li J, Mulvihill TS, Li L, et al. A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction. Cancer Discov. 2021. PMID: 34078620. doi:10.1158/2159-8290.CD-20-1219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。